Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China

BACKGROUND: Plasmablastic lymphoma (PBL) is a rare but aggressive B-cell lymphoma subtype with poor prognosis. Knowledge about the etiology, clinicopathologic and molecular features, and outcomes of PBL is limited. This study aimed to examine the clinicopathologic characteristics, therapeutic approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Di, Gao, Lin, Wan, Xiao-Chun, Li, Jin, Tian, Tian, Hu, Jue, Zhang, Qun-Ling, Su, Yi-Fan, Zeng, Yu-Peng, Hu, Zi-Juan, Yu, Bao-Hua, Li, Xiao-Qiu, Wei, Ping, Li, Ji-Wei, Zhou, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753322/
https://www.ncbi.nlm.nih.gov/pubmed/36522654
http://dx.doi.org/10.1186/s12916-022-02683-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753322/
https://www.ncbi.nlm.nih.gov/pubmed/36522654
http://dx.doi.org/10.1186/s12916-022-02683-9

Ejemplares similares